Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
L. Chen
Observed name:
L Chen
Institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute
Observed institutions:
City Of Hope National Medical Center,
City of Hope,
Beckman Research Institute
OpenAlex ID:
A5016706978
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
2010
·
A Scuto
, P Krejci
, et al.
·
Leukemia
·
161
671 | Glofitamab for the Treatment of Relapsed/refractory Diffuse Large B Cell Lymphoma, a Real‐world Evidence Study From the Cubic Consortium
2025
·
G. Shouse
, S. Ahmed
, et al.
·
Hematological Oncology
·
3
PDF
813 | Phase Ii Investigator‐initiated Trial of Epcoritamab‐lenalidomide in Treatment Naïve Follicular Lymphoma
2025
·
S. Thiruvengadam
, L. Chen
, et al.
·
Hematological Oncology
PDF
399 | Durvalumab and Lenalidomide Shows Superior Efficacy Over Single‐agent Durvalumab in Refractory/advanced Cutaneous T Cell Lymphoma: Results From a Randomized Phase 2 Trial
2025
·
C. Querfeld
, L. Chen
, et al.
·
Hematological Oncology
PDF
Role Of Radiation In Relapses In Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) Post-Transplant
2020
·
S.V. Dandapani
, L. Chen
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Show more works
View as search
Works count:
5
Citation count:
164
H-index:
2
I10-index:
1
Year
Topic
Type